Brief: PCI Biotech Q4 operating loss lowers to NOK 6.9 million
Feb 28 (Reuters) - PCI Biotech Holding Asa PCIB.OL
* Q4 operating loss of 6.9 million Norwegian crowns
($825,161) versus loss of 8.5 million crowns year ago
Source text for Eikon: ID:nGNE2rkrNW
Further company coverage: PCIB.OL
($1 = 8.3620 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process